Infection Control Market Size Worth USD 71.70 Billion in 2032 By Emergen Research

In the healthcare industry, the infection control market is one area that is expanding quickly. Measures done to stop the spread of infectious diseases in healthcare settings, such as hospitals, clinics, and long-term care institutions, are referred to as infection control. The global COVID-19 pandemic has caused a surge in demand for infection control goods and services, but this growth is anticipated to continue as healthcare facilities realise the value of preventing healthcare-associated infections (HAIs) and ensuring patient safety.

The rising incidence of HAIs is one of the major factors driving the infection control industry. The Centres for Disease Control and Prevention (CDC) estimate that there are 1.7 million HAIs in the US annually, which result in 99,000 fatalities and $20 billion in medical expenses. In order to lower the prevalence of HAIs and enhance patient outcomes, healthcare facilities are investing in infection control goods and services.

The growing emphasis on patient safety and quality of care is another factor driving the infection control industry. Preventing HAIs is a crucial step in helping healthcare facilities meet their pressure to deliver high-quality treatment while cutting costs. Healthcare institutions may meet regulatory standards, increase patient happiness, and avoid exorbitant fines for noncompliance by using infection control products and services.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1844

However, the market for infection control also faces a number of obstacles. The price of products and services for infection control is one of the major issues. If healthcare facilities believe infection control methods to be too expensive or are already working on tight budgets, they may be hesitant to make the investment. Additionally, patients and healthcare professionals might not be aware of or understand the significance of infection control measures.

Despite these obstacles, the infection control market is being driven by a number of growth factors. The growing use of technology for infection control is one of them. For instance, to increase adherence to hand hygiene recommendations and lower the risk of HAIs, several healthcare facilities are putting electronic hand hygiene monitoring systems in place. Similar to this, the usage of ultraviolet (UV) disinfection systems is expanding in healthcare facilities as a means of reducing the spread of diseases.

The growing need for outsourcing infection control services is another major element in the market for infection control. Many healthcare facilities are using outside companies that can provide specialised knowledge and resources to handle their infection control needs. This pattern is anticipated to persist as healthcare facilities look to cut expenses and boost productivity.

Major Companies and Competitive Landscape:

The infection control market is highly competitive, with a large number of players offering a variety of products and services to healthcare facilities. Some of the major players in the market include 3M, Belimed AG, Steris PLC., Getinge AB, Advanced Sterilization Products (ASP), MMM Company., MATACHANA, O&M Halyard, Sterigenics U.S., LLC., and Ecolab.

3M Company is a leading player in the infection control market, offering a range of products such as hand hygiene solutions, surface disinfectants, and sterilization products. The company's infection prevention division generated $1.6 billion in sales in 2020, driven in part by increased demand for its products during the COVID-19 pandemic.

STERIS Corporation is another major player in the infection control market, offering a variety of products and services including sterilization systems, endoscope reprocessing systems, and environmental monitoring solutions. The company reported $3.0 billion in revenue in 2020, with its healthcare segment accounting for a significant portion of its sales.

Ecolab Inc. is a global provider of water, hygiene, and energy technologies and services, including infection control products and services for healthcare facilities. The company's healthcare division generated $1.9 billion in revenue in 2020, driven in part by increased demand for its hand hygiene and surface disinfectant products during the COVID-19 pandemic.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1844

Segmentation Insights for Infection Control Market Report:

The global infection control market is segmented by product and service, end-use, and region. In terms of product and service, the market includes sterilization products and services, cleaning and disinfectant products, protective barrier supplies, and endoscope processing products. The sterilization products and services segment includes sterilization equipment and contract sterilization services, as well as consumables and accessories. The cleaning and disinfectant products segment includes cleaning and disinfectant equipment and disinfection and cleaning accessories. The endoscope processing products segment includes endoscope reprocessing consumables and equipment.

In terms of end-use, the infection control market includes hospitals and clinics, pharmaceutical and biotechnology companies, and others. Hospitals and clinics are the largest end-user segment, as these facilities require extensive infection control measures to prevent the spread of healthcare-associated infections. Pharmaceutical and biotechnology companies are also a significant end-user segment, as these facilities must maintain strict standards of hygiene and sterility to ensure the safety and efficacy of their products.

Geographically, the infection control market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the largest regional market, with the United States accounting for the majority of revenue. The high demand for infection control products and services in this region is driven by the presence of a large number of healthcare facilities, as well as a growing focus on infection prevention and control in light of the COVID-19 pandemic.

Europe is another significant market for infection control products and services, with Germany, France, the United Kingdom, and Italy among the largest markets in the region. The Asia Pacific region is expected to exhibit strong growth over the forecast period, driven by increasing demand for infection control products and services in countries such as China, India, and Japan.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/infection-control-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.